Literature DB >> 32099242

A Promising New Anti-Cancer Strategy: Iron Chelators Targeting CSCs.

Yuehua Chen1,2, Toshiaki Ohara1,3, Boyi Xing1, Jiping Qi2, Kazuhiro Noma3, Akihiro Matsukawa1.   

Abstract

Iron is a trace but vital element in the human body and is necessary for a multitude of crucial processes in life. However, iron overload is known to induce carcinogenesis via oxidative stress. Cancer cells require large amounts of iron for their rapid division and cell growth. Iron was recently found to play a role in cancer stem cells (CSCs); it maintains stemness during development. Iron also plays an important role in stemness by moderating reactive oxygen species. Thus, iron metabolism in CSCs is a promising therapeutic target. In this review, we summarize the roles of iron in cancer cells and CSCs. We also summarize anti-cancer therapeutic studies with iron chelators and describe our expectation of a new therapeutic strategy for CSCs on the basis of our findings.

Entities:  

Keywords:  cancer stem cell; chelation; chemotherapy; iron; stemness

Year:  2020        PMID: 32099242     DOI: 10.18926/AMO/57946

Source DB:  PubMed          Journal:  Acta Med Okayama        ISSN: 0386-300X            Impact factor:   0.892


  2 in total

Review 1.  Iron imbalance in cancer: Intersection of deficiency and overload.

Authors:  Tulika Basak; Rupinder Kaur Kanwar
Journal:  Cancer Med       Date:  2022-04-22       Impact factor: 4.711

2.  Ceruloplasmin correlates with immune infiltration and serves as a prognostic biomarker in breast cancer.

Authors:  Fei Chen; Bihui Han; Yanxiu Meng; Yu Han; Bing Liu; Bo Zhang; Yanzhong Chang; Pengxiu Cao; Yumei Fan; Ke Tan
Journal:  Aging (Albany NY)       Date:  2021-08-19       Impact factor: 5.682

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.